Literature DB >> 28620886

To Improve Translational Research in Subarachnoid Hemorrhage.

Hidenori Suzuki1, Fumi Nakano2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28620886     DOI: 10.1007/s12975-017-0546-2

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


× No keyword cloud information.
  31 in total

1.  What is early brain injury?

Authors:  Hidenori Suzuki
Journal:  Transl Stroke Res       Date:  2014-12-16       Impact factor: 6.829

Review 2.  Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia.

Authors:  David W Howells; Michelle J Porritt; Sarah S J Rewell; Victoria O'Collins; Emily S Sena; H Bart van der Worp; Richard J Traystman; Malcolm R Macleod
Journal:  J Cereb Blood Flow Metab       Date:  2010-05-19       Impact factor: 6.200

Review 3.  Anesthesia in Experimental Stroke Research.

Authors:  Ulrike Hoffmann; Huaxin Sheng; Cenk Ayata; David S Warner
Journal:  Transl Stroke Res       Date:  2016-08-17       Impact factor: 6.829

4.  Higher Cerebrospinal Fluid pH may Contribute to the Development of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage.

Authors:  Hidenori Suzuki; Masato Shiba; Yoshinari Nakatsuka; Fumi Nakano; Hirofumi Nishikawa
Journal:  Transl Stroke Res       Date:  2016-09-14       Impact factor: 6.829

Review 5.  Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes.

Authors:  Adviye Ergul; Sherif Hafez; Abdelrahman Fouda; Susan C Fagan
Journal:  Transl Stroke Res       Date:  2016-03-30       Impact factor: 6.829

Review 6.  The Importance of Considering Sex Differences in Translational Stroke Research.

Authors:  Hilda Ahnstedt; Louise D McCullough; Marilyn J Cipolla
Journal:  Transl Stroke Res       Date:  2016-02-01       Impact factor: 6.829

Review 7.  Stem Cell Therapy and Administration Routes After Stroke.

Authors:  Berta Rodríguez-Frutos; Laura Otero-Ortega; María Gutiérrez-Fernández; Blanca Fuentes; Jaime Ramos-Cejudo; Exuperio Díez-Tejedor
Journal:  Transl Stroke Res       Date:  2016-07-07       Impact factor: 6.829

8.  Progress in using systematic reviews of animal studies to improve translational research.

Authors:  C R Hooijmans; M Ritskes-Hoitinga
Journal:  PLoS Med       Date:  2013-07-16       Impact factor: 11.069

9.  Phase III Preclinical Trials in Translational Stroke Research: Community Response on Framework and Guidelines.

Authors:  Johannes Boltze; Daniel-Christoph Wagner; Nils Henninger; Nikolaus Plesnila; Cenk Ayata
Journal:  Transl Stroke Res       Date:  2016-06-14       Impact factor: 6.829

Review 10.  Neuroimaging as a Selection Tool and Endpoint in Clinical and Pre-clinical Trials.

Authors:  Keith W Muir; I Mhairi Macrae
Journal:  Transl Stroke Res       Date:  2016-08-20       Impact factor: 6.829

View more
  18 in total

1.  Inflammation: a Good Research Target to Improve Outcomes of Poor-Grade Subarachnoid Hemorrhage.

Authors:  Hidenori Suzuki
Journal:  Transl Stroke Res       Date:  2019-06-18       Impact factor: 6.829

Review 2.  Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage.

Authors:  Takeshi Okada; Hidenori Suzuki
Journal:  Histol Histopathol       Date:  2020-02-06       Impact factor: 2.303

3.  Experimental Aneurysmal Subarachnoid Hemorrhage: Tiding Over.

Authors:  Marcel A Kamp; Hans-Jakob Steiger; Jasper Hans van Lieshout
Journal:  Transl Stroke Res       Date:  2019-09-02       Impact factor: 6.829

4.  Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm.

Authors:  Michael Hugelshofer; Raphael M Buzzi; Christian A Schaer; Henning Richter; Kevin Akeret; Vania Anagnostakou; Leila Mahmoudi; Raphael Vaccani; Florence Vallelian; Jeremy W Deuel; Peter W Kronen; Zsolt Kulcsar; Luca Regli; Jin Hyen Baek; Ivan S Pires; Andre F Palmer; Matthias Dennler; Rok Humar; Paul W Buehler; Patrick R Kircher; Emanuela Keller; Dominik J Schaer
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

5.  Acute-Phase Plasma Osteopontin as an Independent Predictor for Poor Outcome After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Yoshinari Nakatsuka; Masato Shiba; Hirofumi Nishikawa; Mio Terashima; Fumihiro Kawakita; Masashi Fujimoto; Hidenori Suzuki
Journal:  Mol Neurobiol       Date:  2018-01-20       Impact factor: 5.590

6.  The protective effect of low-dose minocycline on brain microvascular ultrastructure in a rodent model of subarachnoid hemorrhage.

Authors:  Daria Gendosz de Carrillo; Sebastian Student; Daniel Bula; Łukasz Mielańczyk; Małgorzata Burek; Patrick Meybohm; Halina Jędrzejowska-Szypułka
Journal:  Histochem Cell Biol       Date:  2022-09-24       Impact factor: 2.531

7.  Activation of TGR5 with INT-777 attenuates oxidative stress and neuronal apoptosis via cAMP/PKCε/ALDH2 pathway after subarachnoid hemorrhage in rats.

Authors:  Gang Zuo; Tongyu Zhang; Lei Huang; Camila Araujo; Jun Peng; Zachary Travis; Takeshi Okada; Umut Ocak; Guangyu Zhang; Jiping Tang; Xiaojun Lu; John H Zhang
Journal:  Free Radic Biol Med       Date:  2019-09-04       Impact factor: 7.376

Review 8.  Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Authors:  Hidenori Suzuki; Hideki Kanamaru; Fumihiro Kawakita; Reona Asada; Masashi Fujimoto; Masato Shiba
Journal:  Histol Histopathol       Date:  2020-09-30       Impact factor: 2.303

Review 9.  Possible Role of Inflammation and Galectin-3 in Brain Injury after Subarachnoid Hemorrhage.

Authors:  Hirofumi Nishikawa; Hidenori Suzuki
Journal:  Brain Sci       Date:  2018-02-07

10.  AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats.

Authors:  Jun Mo; Budbazar Enkhjargal; Zachary D Travis; Keren Zhou; Pei Wu; Guangyu Zhang; Qiquan Zhu; Tongyu Zhang; Jianhua Peng; Weilin Xu; Umut Ocak; Yili Chen; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Redox Biol       Date:  2018-09-28       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.